AIM: £4.88 (+0.02) | Nasdaq: $31.72 (-0.68)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
商業平台, 監管信息公告 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture